Maria Alfaiate

SVP New Products Commercialisation and Portfolio Strategy, Bayer

EVP of commercial and corporate strategy at Lundbeck

About

Female

Maria Alfaiate is the current EVP of commercial and corporate strategy Lundbeck. She previously worked at AstraZeneca as a Global Brand Director. Maria Alfaiate attended the University of Coimbra.

Experience

Lundbeck

EVP of commercial and corporate strategy · 2024 – present

View →

IPO6.0kValby, Hovedstaden, DenmarkBiotech/Pharma · Health Care

SVP New Products Commercialisation and Portfolio Strategy · Bayer
2021 – present

Education

University of Coimbra · Masters, Clinical Psychology
1993 – 1998

Headlines from Google News. Social posts load from the platform only when you open a tab.

Lundbeck 'not willing to compromise' on M&A strategy after missed Avadel attempt: exec
Fierce Pharma · Jan 22
Large drugmakers without a US pricing pact are bracing to make one
Endpoints News · Jan 20
Lundbeck CEO assembles dream executive team to "transform" business
medwatch.com · May 23
Lundbeck appoints Maria Alfaiate EVP of commercial and corporate strategy
medwatch.com · May 13

People at Lundbeck

Executive Vice President & Chief Financial Officer

Data from: crunchbase